Systematic Development and Optimization of Inhalable Pirfenidone Liposomes for Non-Small Cell Lung Cancer Treatment

Non-small cell lung cancer (NSCLC) is a global disorder, treatment options for which remain limited with resistance development by cancer cells and off-target events being major roadblocks for current therapies. The discovery of new drug molecules remains time-consuming, expensive, and prone to fail...

Descripción completa

Detalles Bibliográficos
Autores principales: Parvathaneni, Vineela, Kulkarni, Nishant S., Shukla, Snehal K., Farrales, Pamela T., Kunda, Nitesh K., Muth, Aaron, Gupta, Vivek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150896/
https://www.ncbi.nlm.nih.gov/pubmed/32121070
http://dx.doi.org/10.3390/pharmaceutics12030206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150896/
https://www.ncbi.nlm.nih.gov/pubmed/32121070
http://dx.doi.org/10.3390/pharmaceutics12030206

Ejemplares similares